At the UCSD Neuroscience, Movement Disorder Center, Irene Litvan, M.D., director of its Movement Disorders Program, is seeking volunteers in the La Jolla/San Diego county area, to participate in a Parkinson’s disease (PD) clinical research study evaluating the effects of the investigational use of AZILECT® (rasagiline tablets) on mild cognitive impairment (PD-MCI). Currently, there are no treatments available indicated for PD-MCI, so any therapy demonstrating a benefit would be a welcomed step toward meeting a significant unmet need in the community. The trials are targeted to women and men from age 45 to 80 years old with Parkinson’s disease, meeting specified criteria. The recruitment period will continue through March 2014.
This clinical trial, sponsored by Teva Pharmaceuticals, will not only further the understanding of Parkinson’s disease and a potential treatment but will also provide participants with:
• Clinical trial participation at no cost
• Study related care at a health care facility, and
• Study related health care monitoring
PD, a chronic and progressive disorder of the brain and central nervous system, affects an estimated one million people in the U.S. The cause of PD is still unknown. However, many researchers believe it may be caused by a combination of genetic factors and environmental factors, such as exposure to certain toxins.
To volunteer, call 1-800-896-5855 (press option 3) or visit http://clinicaltrials.gov/ct2/show/NCT01723228?term=Azilect&rank=12ii